MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Pharmaceutical Development and Clinical Trials (Facts & Figures)
2018: The top 15 pharma companies by 2017 revenue
Amgen Inc. (NASDAQ:AMGN)
Finance & Acquisitions: Amgen
Parents
Amgen Inc. (NASDAQ:AMGN)
Children
*Portfolio Companies: Amgen
2005: $12b (2005)
2006: $84b market cap (2006)
2011: Micromet deal with Amgen could reap $976 million (2011)
2012: Amgen to buy KAI Pharma for $315M cash (2012)
2012: Amgen to buy Micromet for $1.16 billion (2012)
2013: Amgen Agrees to Buy Onyx for $125 Per Share, or $10.4B (2013)
2013: In this round, investors Amgen Ventures (Nasdaq: AMGN), Celgene Corporation (Nasdaq: CELG), and EcoR1 Capital, joined existing investors Alexandria Venture Investments, DAG Ventures, Domain Associates, and Kleiner Perkins Caufield & Byers,(2013)
2015: Top Stock Regeneron Breaks Out On Big Drug News, In Buy Range REGN
2019: Amgen Is Taking A $2.7 Billion Stake In A Chinese Biotech — Beigene_Here's Whywww.investors.com
2020: Amgen doubles down on BeiGene investment as Chinese biotech aims to raise $2.1B
2021: Amgen Invites Applications for Migraine Research
2021: Amgen Snaps Up Five Prime for $1.9 Billion to Bolster Oncology Portfolio
2021: Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash| Amgen
2021: Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments
2021: In Second Acquisition this Month, Amgen Buys Rodeo for $721 Million
2022: AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
2022: Amgen to Buy Horizon in Biotech’s Biggest Deal of 2022
2025: Amgen Inc. 2024 Q4 - Results - Earnings Call Presentation
Abgenix
Amgen Ventures
AMGN, Amgen Inc
Avidia
BioVex
ChemoCentryx, Inc., (NASDAQ:CCXI)
Five Prime Therapeutics (NASDAQ:FPRX)
FivePrime Therapeutics
Horizon Therapeutics plc (NASDAQ: HZNP)
Immunex
KAI Pharmaceuticals
Micromet
Onyx Pharmaceuticals (NASDAQ: ONXX)
Revenue: $28.19 billion USD (2023)
Rodeo Therapeutics
TeneoBio
Jumps
*Key People: Amgen
Organization & Developments: Amgen